December 21 Drugs & Diseases On the Shelf Dancing to the beet PT December 2022 Beetroot juice is well-known in the sports community as a postworkout must and performance enhancer. Mickie Cathers
December 21 Drugs & Diseases New Drug Approval of new ALS drug comes with controversy PT December 2022 After 5 years with no breakthroughs for patients living with amyotrophic lateral sclerosis (ALS), FDA has approved a new oral treatment called Relyvrio from Amylyx Pharmaceuticals. Lauren Howell, PharmD
December 21 Drugs & Diseases Alzheimer Disease Eisai to seek FDA approval for lecanemab, one of dozens of drugs in the Alzheimer pipeline PT December 2022 This fall, biotech Biogen and pharmaceutical company Eisai released topline data on their new antiamyloid monoclonal antibody le-canemab. Sonya Collins
December 21 Drugs & Diseases Biosimilars Ten Humira biosimilars headed to market in 2023 PT December 2022 At least 7 biosimilars for adalimumab (Humira–AbbVie, Inc.) are expected to hit the market in 2023. Sonya Collins
December 21 Drugs & Diseases Diabetes What additional medications might be best for patients taking metformin? PT December 2022 Two recently published articles in the New England Journal of Medicine looked at the comparative efficacy of different medications for the treatment of type 2 diabetes. Johanna Taylor Katroscik, PharmD
December 21 Practice & Trends On the Cover Getting naloxone in the hands of those who need it most PT December 2022 Harm reduction experts know that naloxone isn't the single solution to the opioid overdose crisis. Loren Bonner
December 21 Practice & Trends AFIB Pharmacists have future role in atrial fibrillation management PT December 2022 Pharmacists are a potentially untapped resource for atrial fibrillation (AFib) management, according to a new research paper in the American Journal of Medicine. Loren Bonner
December 21 Practice & Trends Vaccine Errors ISMP identifies non-COVID-19-related vaccine errors PT December 2022 In a recent report published by the Institute of Safe Medical Practices (ISMP), more than 1,400 vaccine-related errors were reported and analyzed within the ISMP National Vaccine Errors Reporting Program (ISMP VERP) during a 19-month period from June 2020 to December 2021. Ariel L. Clark, PharmD
December 21 Practice & Trends Flu Shots Top 5 questions about this year's flu vaccination PT December 2022 CDC estimates that the United States will experience a high influenza disease burden for the 2022–2023 season. Brooke Whittington, PharmD
December 21 Practice & Trends On the Docket Court holds that pharmaceutical product placement may be a representation of product quality PT December 2022 Most states have consumer protection laws that authorize lawsuits against retailers who represent their products as having characteristics that the products actually do not have. David B. Brushwood, BSPharm, JD